Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | CAR T-cells for MM: where are we going?

Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, discusses the different trial efforts of CAR T-cells for the treatment of multiple myeloma at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.